Retatrutide is a multi-receptor metabolic compound studied for its powerful effects on weight regulation, appetite control, energy balance, and metabolic efficiency.

What makes it unique is that it activates three key hormone receptors involved in metabolism:

• GLP-1 (glucagon-like peptide-1) – appetite regulation & blood sugar control

• GIP (glucose-dependent insulinotropic polypeptide) – metabolic signaling & insulin response

• Glucagon receptor – increased energy expenditure & fat burning

By targeting all three, retatrutide is designed to influence both calorie intake and calorie burning.

Appetite regulation & satiety signaling

Through GLP-1 and GIP pathways, retatrutide is studied for:

• Reducing hunger signals
• Increasing feelings of fullness
• Slowing gastric emptying (food stays in the stomach longer)

This leads to:

• Lower overall calorie intake
• Reduced appetite signaling
• Reduced food-seeking behaviour in models

Increased energy expenditure & fat metabolism

By activating the glucagon receptor, retatrutide can:

• Increase fat breakdown (lipolysis)
• Boost metabolic rate and energy use
• Encourage the body to use stored fat as fuel

This sets it apart from compounds that mainly suppress appetite.

Blood sugar control & metabolic efficiency

Retatrutide also supports:

• Improved insulin sensitivity
• More stable blood glucose levels
• Healthier metabolic signaling

These effects are important for overall metabolic health and body composition regulation.